바이오로직스 자료
Overcoming Bottlenecks in mRNA Manufacturing
Having the right CDMO partner with the ability to provide end-to-end services, eliminating the need to manage multiple providers, is a huge advantage for developers of mRNA therapies and vaccines. In this whitepaper, Pierre Catignol, EVP and Head of Manufacturing, and Huisub Lim, Lead Scientist in mRNA manufacturing, provide insights on how a one-stop solution provider like Samsung Biologics can help you overcome bottlenecks in the mRNA manufacturing process and successfully deliver your molecule to market.
Having the right CDMO partner with the ability to provide end-to-end services, eliminating the need to manage multiple providers, is a huge advantage for developers of mRNA therapies and vaccines. In this whitepaper, Pierre Catignol, EVP and Head of Manufacturing, and Huisub Lim, Lead Scientist in mRNA manufacturing, provide insights on how a one-stop solution provider like Samsung Biologics can help you overcome bottlenecks in the mRNA manufacturing process and successfully deliver your molecule to market.